Mesenchymal stem cell (MSC) potency assessment is an essential step to establish the cell quality prior to their therapeutic application, and, as such, it is a regulatory requirement. For this purpose, ECELLFrance has developed standards for potency tests and safety controls on cultured MSC from bone marrow (BM-MSC) and adipose tissue (ASC).
ECELLFrance’s QC/potency platform is located in Toulouse. It is a key facility downstream of cell production for safety and quality assessment of the cells.
The service offering consists in two QC/potency packages (level 1 or 2) to choose from, based on the cell therapeutic applications and the aims of the project. Customized QC/potency assays may also be implemented when appropriate. The QC/potency options are discussed with the project carriers following their application. Key QC/potency offering is summarized below.
The platform has a high expertise of MSC/ASC allowing to a personalized service by a team of specialists (experience in over 20 national and European clinical trial programs in cell therapy using MSC).
Requests for support (service provision or research agreement) can be submitted by filling the online submission form.